U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H27N3O5
Molecular Weight 377.4348
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTANAMIDE, 2,3-DIHYDROXY-3-METHYL-N-((1S)-1-METHYL-2-OXO-2-(((1S)-2,3,4,5-TETRAHYDRO-3-METHYL-2-OXO-1H-3-BENZAZEPIN-1-YL)AMINO)ETHYL)-, (2S)-

SMILES

C[C@H](NC(=O)[C@@H](O)C(C)(C)O)C(=O)N[C@H]1C2=C(CCN(C)C1=O)C=CC=C2

InChI

InChIKey=YUMJKDNNVNRUDW-TUKIKUTGSA-N
InChI=1S/C19H27N3O5/c1-11(20-17(25)15(23)19(2,3)27)16(24)21-14-13-8-6-5-7-12(13)9-10-22(4)18(14)26/h5-8,11,14-15,23,27H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t11-,14-,15+/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
BUTANAMIDE, 2,3-DIHYDROXY-3-METHYL-N-((1S)-1-METHYL-2-OXO-2-(((1S)-2,3,4,5-TETRAHYDRO-3-METHYL-2-OXO-1H-3-BENZAZEPIN-1-YL)AMINO)ETHYL)-, (2S)-
Systematic Name English
SEMAGACESTAT METABOLITE M4
Common Name English
Code System Code Type Description
PUBCHEM
155928908
Created by admin on Sat Dec 16 16:26:45 GMT 2023 , Edited by admin on Sat Dec 16 16:26:45 GMT 2023
PRIMARY
FDA UNII
G3XAH7T8HW
Created by admin on Sat Dec 16 16:26:45 GMT 2023 , Edited by admin on Sat Dec 16 16:26:45 GMT 2023
PRIMARY
CAS
1296772-45-6
Created by admin on Sat Dec 16 16:26:45 GMT 2023 , Edited by admin on Sat Dec 16 16:26:45 GMT 2023
PRIMARY